de Ridder C - Search Results

1

Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition.

Buck SAJ, Van Hemelryk A, de Ridder C, Stuurman D, Erkens-Schulze S, van 't Geloof S, Teubel WJ, Koolen SLW, Martens-Uzunova ES, van Royen ME, de Wit R, Mathijssen RHJ, van Weerden WM. Buck SAJ, et al. Among authors: de ridder c. Mol Cancer Ther. 2024 May 2;23(5):711-720. doi: 10.1158/1535-7163.MCT-23-0420. Mol Cancer Ther. 2024. PMID: 38030379

2

Pre- and Intraoperative Visualization of GRPR-Expressing Solid Tumors: Preclinical Profiling of Novel Dual-Modality Probes for Nuclear and Fluorescence Imaging.

Verhoeven M, Handula M, van den Brink L, de Ridder CMA, Stuurman DC, Seimbille Y, Dalm SU. Verhoeven M, et al. Among authors: de ridder cma. Cancers (Basel). 2023 Apr 5;15(7):2161. doi: 10.3390/cancers15072161. Cancers (Basel). 2023. PMID: 37046825 Free PMC article.

3

Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer.

Murce E, Beekman S, Spaan E, Handula M, Stuurman D, de Ridder C, Seimbille Y. Murce E, et al. Among authors: de ridder c. Molecules. 2023 May 11;28(10):4022. doi: 10.3390/molecules28104022. Molecules. 2023. PMID: 37241763 Free PMC article.

4

DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivo.

Reuvers TGA, Verkaik NS, Stuurman D, de Ridder C, Groningen MCC, de Blois E, Nonnekens J. Reuvers TGA, et al. Among authors: de ridder c, de blois e. Theranostics. 2023 May 21;13(10):3117-3130. doi: 10.7150/thno.82963. eCollection 2023. Theranostics. 2023. PMID: 37351169 Free PMC article.

5

Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics.

Murce E, Ahenkorah S, Beekman S, Handula M, Stuurman D, de Ridder C, Cleeren F, Seimbille Y. Murce E, et al. Among authors: de ridder c. Pharmaceuticals (Basel). 2023 Jun 15;16(6):882. doi: 10.3390/ph16060882. Pharmaceuticals (Basel). 2023. PMID: 37375829 Free PMC article.

6

First preclinical evaluation of [²²⁵Ac]Ac-DOTA-JR11 and comparison with [¹⁷⁷Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs.

Handula M, Beekman S, Konijnenberg M, Stuurman D, de Ridder C, Bruchertseifer F, Morgenstern A, Denkova A, de Blois E, Seimbille Y. Handula M, et al. Among authors: de ridder c, de blois e. EJNMMI Radiopharm Chem. 2023 Jun 30;8(1):13. doi: 10.1186/s41181-023-00197-0. EJNMMI Radiopharm Chem. 2023. PMID: 37389800 Free PMC article.

7

Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids.

Van Hemelryk A, Erkens-Schulze S, Lim L, de Ridder CMA, Stuurman DC, Jenster GW, van Royen ME, van Weerden WM. Van Hemelryk A, et al. Among authors: de ridder cma. Cells. 2023 May 12;12(10):1377. doi: 10.3390/cells12101377. Cells. 2023. PMID: 37408211 Free PMC article.

8

[²¹²Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors.

Chapeau D, Koustoulidou S, Handula M, Beekman S, de Ridder C, Stuurman D, de Blois E, Buchatskaya Y, van der Schilden K, de Jong M, Konijnenberg MW, Seimbille Y. Chapeau D, et al. Among authors: de ridder c. Pharmaceuticals (Basel). 2023 Jul 10;16(7):985. doi: 10.3390/ph16070985. Pharmaceuticals (Basel). 2023. PMID: 37513897 Free PMC article.

9

Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical setting.

Damiana TST, Paraïso P, de Ridder C, Stuurman D, Seimbille Y, Dalm SU. Damiana TST, et al. Among authors: de ridder c. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3851-3861. doi: 10.1007/s00259-023-06364-4. Epub 2023 Aug 16. Eur J Nucl Med Mol Imaging. 2023. PMID: 37584725 Free PMC article.

10

Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer.

Murce E, Spaan E, Beekman S, van den Brink L, Handula M, Stuurman D, de Ridder C, Dalm SU, Seimbille Y. Murce E, et al. Among authors: de ridder c. Pharmaceuticals (Basel). 2023 Jul 28;16(8):1072. doi: 10.3390/ph16081072. Pharmaceuticals (Basel). 2023. PMID: 37630990 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters